Ex vivo expanded murine bone marrow cells with a multiple cytokine cocktail retain long-term hematopoietic reconstitution potentials

Medical Science Monitor

Volumn 11, Issue 6, 2005, Pages

  Yang, Quan En ^a   Fong, Steven E ^a,b   Li, Kungui ^c   Gonda, Matthew A ^a,d   Tobin, Gregory J ^a,e  

^a SAIC FREDERICK INC   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c MUDANJIANG MEDICAL UNIVERSITY   (China)

^d TransMolecular Inc   (United States)

^e Biological Mimetics Inc   (United States)

Author keywords

Bone marrow transplantation; Cytokine; Ex vivo expansion; Hematopoiesis; Hematopoietic stimulation factor; Stem cell

Indexed keywords

BETA GALACTOSIDASE; ERYTHROPOIETIN; LEUKEMIA INHIBITORY FACTOR; MONOCLONAL ANTIBODY; RECOMBINANT COLONY STIMULATING FACTOR 1; RECOMBINANT INTERLEUKIN 3; RECOMBINANT INTERLEUKIN 6; RETROVIRUS VECTOR; STEM CELL FACTOR MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; EX VIVO EXPANSION; EX VIVO STUDY; FEMALE; GENE TRANSFER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MALE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; SPLEEN CELL;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL CULTURE TECHNIQUES; CELL DIVISION; COLONY-FORMING UNITS ASSAY; CYTOKINES; DNA PRIMERS; HEMATOPOIESIS; MALE; MICE; MICE, INBRED BALB C; PHYTOHEMAGGLUTININS; POLYMERASE CHAIN REACTION; SPLEEN; Y CHROMOSOME;

EID: 21344453749     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Popplewell L, Forman SJ: Allogeneic hematopoietic stem cell transplantation for acme leukemia, chronic leukemia, and myelodysplasia. Hematol Oncol Clin North Am, 1999; 13: 987-1015
2. rd Edition. Churchill Livingstone. New York, 2001: 1609-16
3. Busca A, Bruno B, Boccadoro M et al: Allogenic stem cell transplantation following non-myeloablative conditioning regimens as adoptive immunotherapy in patients with hematological malignancies. Med Sci Monit, 2002; 8(10): RA221-RA232
4. Contu L, La Nasa G, Arras M et al: Allogeneic bone marrow transplantation combined with multiple anti-HIV-1 treatment in a case of AIDS. Bone Marrow Transplantation, 1993; 12: 669-71
5. Holland HK, Saral R, Rossi JJ et al: Allogeneic bone marrow transplantation, Zidovudine, and human immunodeficiency virus type-1 (HIV-1) infection. Ann Int Med 1989; 111: 973-81
6. Bortin MM, Buckner CD: Major complications of marrow harvesting for transplantation. Exp Hematol, 1993; 11: 916-21
7. Miller DG, Adam MA, Miller AD: Gene transfer by retroviral vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol. 1990; 10: 4239-42
8. Fletcher FA, Williams DE, Maliszewski C et al: Murine leukemia inhibitory factor enhances retroviral-vector infection efficiency of hematopoietic progenitors. Blood, 1990; 76: 1098-103
9. Szilvassy SJ, Gory S: Efficient retroviral gene transfer to purified long-term repopulating hematopoietic stem cells. Blood, 1994; 84: 74-83
10. Bodine DM, Karlsson S, Niehuis AW: Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci USA, 1989; 86: 8897-902
11. Luskey BD, Rosenblatt M, Zsebo K, Williams DA: Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood, 1992; 80: 396-402
12. Williams DA: Ex vivo expansion of hematopoietic stem and progenitor cells-Robbing Peter to Pay Paul. Blood, 1993; 81: 3169-72
13. McNiece I, Briddell R: Ex vivo expansion of hematopoietic progenitor cells and mature cells. Exp Hematol. 2001; 29: 3-11
14. Pecora AL: Progress in clinical application of use of progenitor cells expanded with hematopoietic growth factors. Curr Opion Hematol. 2001; 8: 142-48
15. Verfaillie CM, Catanzarro PM, Li W: Macrophage inflammatory protein 1α, interleukin 3 and diffusible stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J Exp Med. 1994; 179: 643-49
16. - cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1α maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay. Blood, 1998; 91: 4516-22
17. Theunissen K, Verfaillie CM: A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay. Exp Hematol, 2005; 33: 165-72
18. Erwing J: Accelerated recovery of peripheral blood cell counts in mice transplanted with in vitro cytokine-expanded hematopoietic progenitors. Exp Hematol. 1992; 20: 611-18
19. Varas F, Bernard A, Bueren JA: Restrictions of the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors. Exp Hematol, 1998; 26: 100-9
20. Serrano F, Varas F, Bernard A, Bueren JA: Accelerated and long-term hematopoietic engraftments in mice transplanted with ex vivo expanded bone marrow. Bone Marrow Transplant, 1994; 14: 855-62
21. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire on engraftment defect in normal hosts. Exp Hematol. 1995; 23: 461-69
22. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood, 1996; 87: 30-37
23. Holyoake TL, Freshney MG, McNair L et al: Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serial transplant marrow. Blood, 1996; 87: 4589-95
24. Mardon G, Page DC: The sex-determining region of the mouse Y chromosome encodes a protein with a highly acidic domain and 13 zinc fingers. Cell, 1989; 56: 765-70
25. Stewart FM, Temeles D, Lowry P et al: Post-5-fluorouracil human marrow: stem cell characteristics and renewal properties after autologous marrow transplantation. Blood, 1993; 81: 2283-89
26. Bensinger WI, Weaver CH, Appelbaum FR et al: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulation factor. Blood, 1995; 85: 1655-58
27. Prosper F, Vanoverbeke K, Stroncek D, Verfaillie CM: Primitive long-term culture initiating cells (LTC-Ics) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-Ics in steady stale bone marrow. Blood, 1997; 89: 3991-97
28. Wyrsch A, dale Carbonare V, Jansen W et al: Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity. Exp Hematol. 1999; 27: 1338-45
29. Schmitz N, Barrett J: Optimizing engraftment-source and dose of stem cells. Ser Hematol, 2002; 39: 3-14
30. Grewal SS, Barker JN, Davies SM, Wagner JE: Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood, 2003; 101: 4233-44
31. Wagner JE, Barker JN, DeFor TE et al: Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood, 2002; 100: 1611-18
32. Barker JN, Daniel J et al: Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood, 2005; 105: 1343-47
33. Emerson SG: Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. Blood, 1996; 87: 3082-88
34. Brugger W, Heimfeld S, Berenson RJ et al: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Eng J Med, 1995; 333: 283-87
35. 2/M graft cell content does not correlate with transplantability. Stem Cells, 2001; 19: 436-42
36. Williams SF, Lee WJ, Bender JG et al: Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood, 1996; 87: 1687-91
37. Tisdale JF, Hanazono Y, Sellers SE et al: Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating activity. Blood, 1998; 92: 1131-41
38. + cord blood cells. Blood, 1999; 93: 1097-105
39. McNiece I: Ex vivo expansion of hematopoietic cells. Exp Hematol, 2004; 32: 409-10
40. Berrios VM, Dooner GJ, Nowakowski G et al: The molecular basis for the cytokine-induced defect in homing and engraftment of hematopoietic stem cells. Exp Hematol, 2001; 29: 1326-35
41. Metcalf D: Hematopoietic regulators: redundancy or subtlety? Blood, 1993; 82: 3515-23
42. Janowska-Wieczorek A, Majka M, Ratajczak J, Ratajczak M: Autocrine/ paracrine mechanisms in human hematopoiesis. Stem Cells, 2001; 19: 99-107
43. Hayashi S, Okamura S, Kawasaki C et al: Sequential expression of lymphokine genes during phytohemagglutinin-stimulated mitogenesis of normal human peripheral mononuclear cells. Biomed Pharmacother, 1993; 47: 150-60